Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis

Liver Transplantation

Volumn 7, Issue 4, 2001, Pages 363-373

  Contos, Melissa J ^a   Cales, Wendy ^a   Sterling, Richard K ^a   Luketic, Velimir A ^a   Shiffman, Mitchell L ^a   Mills, A Scott ^a   Fisher, Robert A ^a   Ham, John ^a   Sanyal, Arun J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; IMMUNOSUPPRESSIVE AGENT; LIVER ENZYME; STEROID;

ADULT; AGE; ALCOHOL LIVER DISEASE; ALLOGRAFT; ARTICLE; BODY WEIGHT; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE COURSE; FATTY LIVER; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT REJECTION; HEPATITIS; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; MALE; MULTIVARIATE ANALYSIS; PERIOPERATIVE PERIOD; PHENOTYPE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SEPSIS; SURGICAL MORTALITY; TREATMENT OUTCOME;

EID: 0035052345     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2001.23011     Document Type: Article

References (45)

1. Nonalcoholic steatohepatitis
2. Non-alcoholic steatohepatitis: Another disease of affluence
3. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity
4. Non-alcoholic steatohepatitis (NASH): A disease of emerging identity and importance
5. The spectrum of nonalcoholic fatty liver disease: From steatosis to nonalcoholic steatohepatitis
6. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease
7. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions
8. Diagnosis and interpretation of steatosis and steatohepatitis
9. Fatty liver hepatitis and cirrhosis in obese patients
10. Nonalcoholic steatohepatitis: An expanded clinical entity
11. Recurrence of nonalcoholic steatohepatitis after liver transplantation
12. Recurrent nonalcoholic steatohepatitis and cirrhosis after liver transplantation
13. Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease
14. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case-control study
15. Recurrence of nonalcoholic steatohepatitis in a liver transplant recipient
16. Recurrence of nonalcoholic steatohepatitis following liver transplantation
17. Steatosis and intrahepatic hepatitis C virus in chronic hepatitis
18. Steatosis and bile duct damage in chronic hepatitis C: Distribution and relationships in a group of Northern Italian patients
19. Meeting report of the International Autoimmune Hepatitis Group
20. Nonalcoholic steatohepatitis (NASH): Further expansion of this clinical entity?
21. Mallory body formation runs parallel to g-glutamyl transferase induction in hepatocytes of griseofulvin fed mice
22. Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients
23. Evidence for increased liver glycogen in patients with noninsulin-dependent diabetes mellitus after a 3-day fast
24. The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years
25. Amylin/insulin secretory ratios in morbidly obese man: Inverse relationship with glucose disappearance rate
26. Overweight and obesity in the United States: Prevalence and trends, 1960-1994
27. Non-alcoholic steatohepatitis and iron: Increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis
28. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis
29. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
30. Hepatic iron and nonalcoholic fatty liver disease
31. Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes?
32. Association of nonalcoholic fatty liver disease with insulin resistance
33. Hyperinsulinemia and insulin resistance in non-alcoholic steatohepatitis
34. Insulin resistance: The metabolic syndrome X
35. Non-alcoholic fatty liver: Another feature of the metabolic syndrome?
36. Fatty liver and nonalcoholic steatohepatitis. Where do we stand and where are we going?
37. Liver pathology and the metabolic syndrome X in severe obesity
38. Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
39. The natural history of nonalcoholic fatty liver: A follow-up study
40. Liver abnormalities in severely obese subjects: Effect of drastic weight loss after gastroplasty
41. Hepatic effects of dietary weight loss in morbidly obese subjects
42. Nonalcoholic steatohepatitis: Tightening the morphological screws on a hepatic rambler
43. Parallel reversibility of biological markers of the metabolic syndrome and liver steatosis after gastroplasty-induced weight loss in severe obesity [letter]
44. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
45. Nonalcoholic steatohepatitis in obesity: A reversible condition